Transaction

Oyass Capital's Investment in Eyone Medical's Operations in Senegal for USD 1.7 million

Announced
27 February 2026
Target
Eyone SARL
Value
$1.8m
Asset class
Venture Capital
Type
Investment
Instrument
Ordinary Shares (Equity)
Lead investors
Oyass Capital
Investors
Oyass Capital
Sector
Healthcare / Digital Health Platforms, Health Care Administration
Markets
Gabon, Mali, Cameroon, Senegal, Côte d'Ivoire

About the target

Eyone Medical is a digital health technology company that provides interconnected healthcare solutions connecting patients, healthcare providers, insurers, international organisations, and governments across Africa. The company's flagship product, the Dossier Patient Unique Partagé (Shared Patient Record), digitises healthcare pathways and enables real-time access to medical and financial records. In December 2024, Eyone secured USD 1 million in funding led by SONATEL's VIF fund and BICIS Groupe, the Senegalese affiliate of BNP Paribas. In July 2025, Eyone Medical secured 1.7 billion CFA ($3 million) from Oyass Capital, Senegal's sovereign wealth fund-backed investment vehicle.

Sources

  1. techbuild.africa
  2. Partner Researchers